Authors: Espinel-Ingroff, A Bartlett, M Chaturvedi, V Ghannoum, M Hazen, KC Pfaller, MA Rinaldi, M Walsh, TJ

Citation: A. Espinel-ingroff et al., Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation, ANTIM AG CH, 45(6), 2001, pp. 1828-1835

Authors: Walsh, TJ Viviani, MA Arathoon, E Chiou, C Ghannoum, M Groll, AH Odds, FC

Citation: Tj. Walsh et al., New targets and delivery systems for antifungal therapy, MED MYCOL, 38, 2000, pp. 335-347

Authors: Jessup, C Reyes, G Fothergill, A McCarthy, D Rinaldi, M Messer, S Pfaller, M Ghannoum, M

Citation: C. Jessup et al., A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter study, J CHEMOTHER, 12(1), 2000, pp. 22-29

Authors: Koul, A Vitullo, J Reyes, G Ghannoum, M

Citation: A. Koul et al., Effects of voriconazole on Candida glabrata in vitro, J ANTIMICRO, 44(1), 1999, pp. 109-112

Authors: Pfaller, M Zhang, J Messer, S Tumberland, M Mbidde, E Jessup, C Ghannoum, M

Citation: M. Pfaller et al., Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients, DIAG MICR I, 32(3), 1998, pp. 191-199